agreement was reached with Pipeline Biomedical Holdings on May
1, 2007 to develop and commercialize CSF Detect. Click here
to see the full press release.
fluid (CSF) leaks leading to rhinorrhea or otorrhea are most
commonly the result of trauma. Each year in the United States,
over 1 million people are treated and released from hospital
emergency departments with traumatic head injuries.
An additional 230,000 people are hospitalized with
traumatic head injuries each year. Approximately 2-3% of head
injuries will result in the occurrence of CSF leaks, making this
a relatively common condition seen in hospital emergency rooms.
The risk of recurrent meningitis and cerebritis is very high if
CSF leaks are not repaired. The concern of physicians missing a
CSF leak is very high. The diagnosis of CSF leakage can be
difficult, and often requires the patient to be hospitalized
until the results from laboratory tests can be examined.
and Pipeline Biomedical Holdings have teamed up to develop and
commercialize a rapid test for detecting CSF. Accurate and fast
diagnosis will lead to the right treatments being applied sooner
and medical dollars being spent more wisely.